SCHEMBL7136144

SCHEMBL7136144

CCCNc1cc(Br)cc(S(=O)(=O)c2ccc(N)cc2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 7/20 0.47
CA1 P00915 2/20 0.47
CA2 P00918 2/20 0.47
CA9 Q16790 2/20 0.47
CA12 O43570 1/20 0.47
CYP3A4 P08684 2/20 0.43
LMNA P02545 1/20 0.43
MPO P05164 1/20 0.43
CYP2C9 P11712 1/20 0.43
TSHR P16473 1/20 0.43
PKM P14618 2/20 0.41
CYP2C19 P33261 2/20 0.41
ALDH1A1 P00352 1/20 0.40
GAA P10253 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
HTR2A P28223 1/20 0.38
NPC1 O15118 1/20 0.37
PRMT1 Q99873 2/20 0.37
MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7136181 0.86 HTR6 (0.46) HTR6CA1CA2CA9CA12
SCHEMBL7135857 0.84 HTR6 (0.44) HTR6CA1CA2CA9CA12
SCHEMBL7140761 0.81 HTR6 (0.67) HTR6CA1CA2CA12CYP3A4
SCHEMBL7192584 0.74 HTR6 (0.62) HTR6CA1CA2CA9CA12
SCHEMBL7138913 0.73 HTR6 (0.48) HTR6CA1CA2CA9CA12
SCHEMBL9577459 0.73 CA1 (0.47) HTR6CA1CA2CA9CA12
SCHEMBL7136140 0.71 HTR6 (0.48) HTR6CA1CA2CA9CA12
SCHEMBL7136141 0.71 HTR6 (0.48) HTR6CA1CA2CA9CA12
SCHEMBL9714074 0.71 CA1 (0.44) HTR6CA1CA2CA9CA12
SCHEMBL7138043 0.71 HTR6 (0.54) HTR6CA1CA2CA9CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0930302-B1 Benzosulfone derivatives HOFFMANN LA ROCHE (CH) 2003-04-02 EP claimed
US-5990105-A POSSESS A SELECTIVE AFFINITY TO 5HT-6 RECEPTORS; TREATING OR PREVENTING PSYCHOSES, SCHIZOPHRENIA, MANIC DEPRESSIONS, DEPRESSIONS, NEUROLOGICAL DISORDERS, PARKINSON'S, AMYOTROPHIC LATERAL SCLEROSIS, ALZHEIMER'S AND HUNTINGTON'S DISEASE HOFFMANN-LA ROCHE INC. (US) 1999-11-23 US claimed
EP-0930302-B1 Benzosulfone derivatives HOFFMANN LA ROCHE (CH) 2003-04-02 EP disclosed
US-5990105-A POSSESS A SELECTIVE AFFINITY TO 5HT-6 RECEPTORS; TREATING OR PREVENTING PSYCHOSES, SCHIZOPHRENIA, MANIC DEPRESSIONS, DEPRESSIONS, NEUROLOGICAL DISORDERS, PARKINSON'S, AMYOTROPHIC LATERAL SCLEROSIS, ALZHEIMER'S AND HUNTINGTON'S DISEASE HOFFMANN-LA ROCHE INC. (US) 1999-11-23 US disclosed
EP-0930302-A2 Benzosulfone derivatives F.HOFFMANN-LA ROCHE AG (CH) 1999-07-21 EP disclosed